Pamela Vig
Head of R&D
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Head of Research and Development | $450,000 | $1,507,496 |
| 2019 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Scientific Officer | $354,826 | $2,681,958 |
| 2018 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Scientific Officer | $27,500 | $27,500 |
Earnings-call appearances
-
Mirum Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-02
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-04
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-01-09
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-09
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-03-09
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-15
Mirum Pharmaceuticals, Inc. (MIRM)